Analec Unveils ResearchWise to US Market

singapore-business

Singapore-based Analec, which provides research and infrastructure solutions, has gone live in the United States with ResearchWise, a research platform that is designed specifically for a broker-dealer investment research organization, according to the company.

ResearchWise provides automated research report templates, document management, workflow and compliance management, and distribution capabilities, as well as customizable widgets/plug-ins. The platform has a client list of more than 800 sell-side analysts, more than 100 workflow and compliance professionals, 40 research managers, and distributes reports to more than 100,000 recipients every day, according to the company.

This is the second product that Analec has brought to the US market, after launching its flagship solution, ModelViewer, in April. ModelViewer is a fundamental analysis platform for hedge fund portfolio managers and traders.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

Deutsche Börse democratizes data with Marketplace offering

Deutsche Börse Group is set to unveil its Marketplace, a one-stop data shop designed to simplify and streamline data acquisition and consumption for its clients, while also surfacing data from across the firm to its own users. Jan Stiebing and Sven…

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here